<DOC>
	<DOCNO>NCT02729740</DOCNO>
	<brief_summary>The primary objective study gather post market data Penumbra SMART Coilâ„¢ System treatment intracranial aneurysms malformation .</brief_summary>
	<brief_title>Assessment Embolization Neurovascular Lesions Using Penumbra Smart Coil</brief_title>
	<detailed_description>This prospective , multi-center study patient treat accordance clear indication Penumbra SMART CoilTM System ( Smart ) , Penumbra Coil 400TM ( PC 400 ) , Penumbra Occlusion DeviceTM ( POD ) . Data patient collect accordance standard care participate hospital one-year follow-up . Approximately 1,000 patient intracranial aneurysms malformation treat SMART CoilTM System 100 center enrol . It anticipate patient enrollment take 3 year . All patient assess accordance standard care participate hospital one year follow-up .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>Patients enrol study must sign Informed Consent treat accord cleared indication Smart , PC 400 , POD , include embolization : Intracranial aneurysm Other neurovascular abnormality arteriovenous malformation arteriovenous fistulae Life expectancy less one year Smart , PC 400 , POD account le 75 % total number coil open Participation another clinical investigation could confound evaluation study device</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Penumbra Smart coil</keyword>
	<keyword>PC 400</keyword>
	<keyword>AV malformation</keyword>
	<keyword>AV fistula</keyword>
</DOC>